Neuralink
Founded Year
2016Stage
Series E | AliveTotal Raised
$1.33BValuation
$0000Last Raised
$650M | 5 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+82 points in the past 30 days
About Neuralink
Neuralink focused on developing brain-machine interfaces within the medical technology sector. It offers a device designed to assist individuals with paralysis by providing a means to communicate through a brain-computer interface. The company primarily targets the healthcare sector. It was founded in 2016 and is based in Fremont, California.
Loading...
ESPs containing Neuralink
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The medical brain-computer interfaces (BCIs) market offers innovative solutions for patients with neurological disorders. BCIs are devices that allow direct communication between the brain and an external device, such as a computer or prosthetic limb. This technology has the potential to revolutionize the way we treat conditions such as paralysis, epilepsy, and Parkinson's disease. BCIs can also b…
Neuralink named as Leader among 15 other companies, including Neurable, Stairmed, and Blackrock Neurotech.
Loading...
Research containing Neuralink
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Neuralink in 2 CB Insights research briefs, most recently on Jul 24, 2025.
Jul 24, 2025 report
State of Digital Health Q2’25 Report
Jul 10, 2025 report
State of Venture Q2’25 ReportExpert Collections containing Neuralink
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Neuralink is included in 4 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,297 items
Artificial Intelligence (AI)
37,207 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Generative AI
2,951 items
Companies working on generative AI applications and infrastructure.
Neuralink Patents
Neuralink has filed 33 patents.
The 3 most popular patent topics include:
- implants (medicine)
- integrated circuits
- neuroprosthetics
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/28/2022 | 3/11/2025 | Multiplexing, Implants (medicine), Integrated circuits, Cardiac anatomy, Broadcast engineering | Grant |
Application Date | 2/28/2022 |
|---|---|
Grant Date | 3/11/2025 |
Title | |
Related Topics | Multiplexing, Implants (medicine), Integrated circuits, Cardiac anatomy, Broadcast engineering |
Status | Grant |
Latest Neuralink News
Oct 31, 2025
31. oktoober 2025, 17:29 tehisarufirma OpenAI tegevjuht Sam Altman tahab oma tehisintellektiga ChatGPT lobiseda otse mõttejõul. Erinevalt tehnoloogiamiljardär Elon Muski firmast, kus selleks siirdatakse ajju elektroodid, on tema uus idufirma peenema lahendusega: ajusignaale tahetakse lugeda eemalt, koljut avamata. Foto: Alex Brandon/AP/Scanpix Tehnoloogiamaailma kaks titaani, tehnoloogiamiljardär Elon Musk ja tehisarufirma OpenAI juht Sam Altman olid kunagi lahutamatud kaaslased ühise tehisaru-missiooniga. Nüüd on neist saanud põlised rivaalid . Kuid nagu vanad sõbrad ikka, paistavad nad liikuvat sellesama, peaaegu ulmelise eesmärgi poole. Muskil on oma Neuralink . Ent nüüd sosistatakse kuluaarides, et ka Altman on sisenemas ajuliideste areenile ja tema plaan võib kogu senise mängu pea peale pöörata. Väljaande The Verge ajakirjaniku Alex Heathi uudisloo kohaselt on OpenAI tegevjuht Sam Altman loomas omaenda ajuliidest , mis võiks Muski Neuralinkile tõsist konkurentsi pakkuda. Projekt kannab nime Merge Labs ja Altman on selle kaas-asutanud koos Alex Blania ga, kes on tuntud ka krüptoprojekti Worldcoin (praeguse nimega Tools for Humanity ) juhina. Kuigi ettevõtte tegelike plaanide kohal ripub veel saladuseloor, räägitakse juba sadade miljonite dollarite kaasamisest. Altman ise, kes astub üles kaasasutaja ja nõukogu esimehena, kuid mitte tegevjuhina, on varasemalt öelnud, et teda paelub aju «ainult lugemise» (read-only) liides: «Ma tahaksin mõelda midagi ja lasta ChatGPT-l sellele vastata.,» on ta öelnud.
Neuralink Frequently Asked Questions (FAQ)
When was Neuralink founded?
Neuralink was founded in 2016.
Where is Neuralink's headquarters?
Neuralink's headquarters is located at 7400 Paseo Padre Parkway, Fremont.
What is Neuralink's latest funding round?
Neuralink's latest funding round is Series E.
How much did Neuralink raise?
Neuralink raised a total of $1.33B.
Who are the investors of Neuralink?
Investors of Neuralink include Founders Fund, Google Ventures, VY Capital, Valor Equity Partners, DFJ Growth Fund and 34 more.
Who are Neuralink's competitors?
Competitors of Neuralink include dotLumen, Science, Paradromics, Cognixion, Neurable and 7 more.
Loading...
Compare Neuralink to Competitors
Neurable specializes in brain-computer interface (BCI) technology within the neurotechnology sector. The company offers products that allow users to interact with devices using brain signals. Neurable's technology can be integrated into various applications, including wellness and diagnostics. It was founded in 2015 and is based in Boston, Massachusetts.
Kernel focuses on neuromedicine within the healthcare sector. Its main offerings include non-invasive brain measurement technology that quantifies brain function to assist in treatment development, clinical trial optimization, and early identification of brain health issues. The company primarily serves sectors involved in neuromedicine treatment development and clinical research. It was founded in 2016 and is based in Culver City, California.
Blackrock Neurotech focuses on developing brain-computer interface technology to assist individuals with neurological disorders within the medical device industry. The company offers neural implants for individuals with paralysis and other neurological conditions. Blackrock Neurotech primarily serves the healthcare sector, including patients and research institutions. Blackrock Neurotech was formerly known as I2S Micro Implantable Systems. It was founded in 2008 and is based in Salt Lake City, Utah.
Paradromics develops brain-computer interfaces (BCI) within the healthcare technology sector. The company provides a data interface that captures and interprets neural signals for individuals with neurological and brain-related conditions. Paradromics serves individuals with severe motor impairment resulting from conditions such as ALS, spinal cord injury, or stroke. It was founded in 2015 and is based in Austin, Texas.
Synchron operates as a medical device company. It focuses on the development of minimally invasive neuromodulation technology solutions. It develops an endovascular brain-computer interface to access every corner of the brain using the blood vessels. It offers a switch device to help paralyzed people, such as those with amyotrophic lateral sclerosis (ALS), communicate by controlling computer cursors with their minds. It was founded in 2016 and is based in Brooklyn, New York.
Cognixion develops noninvasive brain-computer interfaces (BCI) within the neurotechnology sector. The company offers products for individuals with complex disabilities, utilizing neuroscience, artificial intelligence, and augmented reality to create assistive and clinical applications. Cognixion's technology is aimed at individuals with accessibility needs, healthcare providers, and researchers in neurotechnology and assistive communication. Cognixion was formerly known as Smartstones. It was founded in 2014 and is based in Toronto, Ontario.
Loading...